首页> 美国卫生研究院文献>Canadian Respiratory Journal >Treatment of a tuberculous empyema with simultaneous oral and intrapleural antituberculosis drugs
【2h】

Treatment of a tuberculous empyema with simultaneous oral and intrapleural antituberculosis drugs

机译:同时口服和胸膜内抗结核药治疗结核性脓胸

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 71-year-old man was diagnosed with an uncomplicated tuberculous (TB) empyema. Differential penetration of anti-TB drugs, believed to explain the phenomenon of acquired drug resistance in TB empyema, was confirmed by measurement of serum and pleural fluid anti-TB drug concentrations. Simultaneous oral and intrapleural anti-TB drugs were administered and a cure was achieved. The present case is discussed in the context of the literature on acquired drug resistance in TB empyema. It is argued that high-end doses of oral drugs or combined oral plus intrapleural drugs, along with tube thoracostomy or intermittent thoracentesis, will cure uncomplicated TB empyema without threatening to induce drug resistance or having to resort to surgery.
机译:一名71岁的男子被诊断患有单纯性结核(TB)脓胸。通过测量血清和胸膜液中的抗结核药物浓度,证实了抗结核药物的差异渗透被认为可以解释结核性脓胸中获得性耐药现象。同时给予口服和胸膜内抗结核药物并治愈。在有关结核性脓胸获得性耐药的文献中讨论了本病例。有人认为,高端剂量的口服药物或口服联合胸膜内注射药物,连同胸腔穿刺造口术或间歇性胸腔穿刺术,可以治愈简单的结核性脓胸,而不会威胁引起耐药性或不得不进行手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号